Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
EMED
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q1.23
+119%
0
vs -0.02
Q2.23
N/A
-0.00
vs -0.01
Q3.23
N/A
-0.00
vs -0.01
Q4.23
N/A
NA
vs -0.01
Q1.24
N/A
NA
vs 0
Q2.24
N/A
NA
vs -0.00
Q3.24
N/A
NA
vs -0.00
Q4.24
N/A
NA
vs NA
Q1.25
N/A
NA
vs NA
Q2.25
N/A
NA
vs NA
Sales Growth
YoY
Current
Estimates
Q1.23
+71%
378.6K vs 221.9K
Q2.23
+31%
295K vs 225.3K
Q3.23
+16%
323.6K vs 279.6K
Q4.23
-17%
351.6K vs 423.1K
Q1.24
-23%
290.2K vs 378.6K
Q2.24
-19%
237.6K vs 295K
Q3.24
-87%
42.5K vs 323.6K
Q4.24
-95%
17.9K vs 351.6K
Q1.25
-95%
14.5K vs 290.2K
Q2.25
-97%
7.1K vs 237.6K
Return on Equity
QoQ
Q1.23
-71%
-0.71
vs 0.7
Q2.23
+64%
0.64
vs -0.71
Q3.23
+15%
0.15
vs 0.64
Q4.23
+12%
0.12
vs 0.15
Q1.24
+23%
0.23
vs 0.12
Q2.24
-7%
-0.07
vs 0.23
Q3.24
+18%
0.18
vs -0.07
Q4.24
-1%
-0.01
vs 0.18
Q1.25
+8%
0.08
vs -0.01
Q2.25
+3%
0.03
vs 0.08
Institutionnal Ownership
N/A
Q3.23
NA
NA
vs NA
NA
Q4.23
NA
NA
vs NA
NA
Q1.24
NA
NA
vs NA
NA
Q2.24
NA
NA
vs NA
NA
Q3.24
NA
NA
vs NA
NA
Q4.24
NA
NA
vs NA
NA
Q1.25
NA
NA
vs NA
NA
Q2.25
NA
NA
vs NA
NA
Q3.25
NA
NA
vs NA
NA
Q4.25
NA
NA
vs NA
NA
prnewswire.com
6 hours ago
accesswire.com
11 hours ago
Forecast
2025-Revenue
2025-EPS
2025-EBITDA
Analyst rating
Price Target
N/A(N/A)
Number of analyst
N/A
Last analyst upgrade/downgrade
No Data Available
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How EMED compares to sector?